A) Quantification Basis
1. Is reported quantity based on absolute calibration against a reference standard, or relative/normalized signal?
Our quantification is typically performed using a known reference standard. This involves creating a calibration curve in which the detector response (peak area) is plotted against known concentrations to confirm linearity. The signal itself is “normalized” by the software, as it calculates the peak area for each signal and reports it as an overall percentage. However, to be clear, we do not manually normalize the HPLC trace beyond this software-based processing.
2. Do you average replicate injections or preparations before reporting a single value?
In research, it is common practice to average the values from repeated measurements of the same sample to obtain statistical information, such as percent error or standard deviation. However, we do not do this for every sample, as it would significantly increase both testing time and cost. Instead, we perform a weekly analysis of a well-characterized material (caffeine), acquiring multiple measurements that provide statistical information about the instrument’s performance. This approach allows evaluation of the method, as well as key components such as the lamp and the column, and is standard practice in many analytical laboratories.
B) Sample Preparation
3. Do you assume full recovery of peptide upon reconstitution, or do you measure recovery implicitly?
We generally assume full recovery upon reconstitution of the lyophilized peptide unless there is clear evidence of poor solubility or degradation (for example, abnormal peak shape or shoulders in the chromatogram). However, recovery is implicitly verified by assessing the total chromatographic area and confirming the expected retention behavior.
4. Do you correct for adsorption, losses, or degradation, or are these reflected in the final number?
No artificial corrections are applied for adsorption or degradation. Any losses during handling, vial adsorption, or solution instability are directly reflected in the final measured value and in the peak shape (by UV or FTIR). In other words, the reported value represents what is actually present and recoverable, rather than an idealized theoretical amount. We try our best to ensure those losses are close to zero.
C) Detection & Calculation
5. Which detector(s) are used for quantification (UV, MS, both), and which signal is authoritative for quantity?
Quantification is primarily performed by UV absorbance (HPLC-UV) because it provides direct, linear response proportional to peptide bond content. Mass spectrometry (MS) is used as a confirmatory tool to verify identity and look for impurities or degradation products, but not as the main signal for quantitative yield due to matrix and ionization variability.
6. How is purity incorporated into quantity (e.g., normalization vs independent measurement)?
Purity is determined separately, by HPLC peak area or by MS profile integration, and used to refine the total quantity. For instance, a sample showing 98% main peak purity means that 98% of the measured UV-derived mass corresponds to the desired peptide. But the final “mg per vial” is calculated as the Mass of vial contents × HPLC purity fraction (reason why we weight the contents of each vial shipped to us).
D) Precision & Uncertainty
7. What is your stated margin of error for this peptide, and does it include preparation + calibration uncertainty?
Typical analytical uncertainty for peptide quantification is ±2–3% when using calibrated HPLC-UV detection under controlled conditions (validated linear range, stable baseline, and a pure reference standard). This includes injection repeatability, calibration curve fitting, and weigh-in precision. Everything in research has a level of error attached to it, not only from the human factor involved, but also the instrumentation. Nothing is 100% accurate.
8. Are reported values rounded, truncated, or raw calculated outputs?
Reported values are rounded to one or two significant digits based on the method’s precision and the instrument sensitivity. A high resolution instrument might be able to provide 3–4 significant figures. For example, a result calculated as 0.987 mg per vial might be reported as 0.99 mg/vial. Raw data are preserved in records but not shown in formatted reports unless requested. Since reporting more significant figures than we can will be a lie.
E) Interpretation
9. Does your reported “mg per vial” represent recovered mass, inferred mass, or label-equivalent mass?
Our “mg per vial” value represents the recovered, quantifiable peptide mass as determined by comparison to a reference standard and corrected for purity. It is not a dry-weight label claim or theoretical yield; it reflects the actual peptide that can be dissolved and detected under the analytical conditions used.
10. Under what conditions would you expect two vials from the same batch to differ by <1%?
For properly filled, homogeneous lots, variation between vials is typically expected to be below 1%, but there are several practical limitations to achieving this ideal level of consistency. These include balance tolerance, lyophilization uniformity, solubility, excipient formulation, and human error, among others. Greater differences can also arise from moisture uptake, static effects, incomplete reconstitution, or sample degradation. To better understand and monitor instrument-related variability, we routinely run our caffeine/uracil OQ to assess performance over time.